GlassScriptPhysician profile
Reynald C Allam
NPI 1831293141
$1,996.17
in general payments reported to CMS, 2019-2025
9 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
See the full distribution for Undersea and Hyperbaric Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $1,018 · 2021: $237 · 2022: $41.19 · 2023: $130 · 2024: $135 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,383.90 | 2019-2025 | Puraply Wound Matrix, Puraply |
| Smith+Nephew, INC. | $248.89 | 2019-2025 | Grafix Pl, Oasis, Regranex |
| Kerecis Limited | $188.37 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Next Science LLC | $52.09 | 2023 | Xperience, Blastx, Surgx |
| Reapplix INC. | $39.96 | 2025 | 3c Patch Kit - Box |
| Cashflow Solutions, LLC | $33.22 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Triad Life Sciences INC. | $18.37 | 2022 | |
| Mimedx Group, INC. | $18.01 | 2025 | |
| Urgo Medical North America, LLC | $13.36 | 2024 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reynald Allam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.